FDA Approval: AMBELVIST (GADOQUATRANE) — Type 1 - New Molecular Entity
Policy FDA-NDA219627 · Radiology
HighAmbelvist (Gadoquatrane) is approved for intravenous administration, indicating that billing will follow the Part B pathway. As it is designated as an orphan drug, it may qualify for special considera
View alertProposed LCD DL40276: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities — Novitas
Policy LCD-DL40276 · Radiology
HighThe proposed LCD for Non-invasive Arterial Duplex Ultrasound may lead to an increase in imaging services for assessing vascular health, impacting reimbursement rates positively for practices that perf
View alertProposed LCD DL40289: Non-invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities — First Coast
Policy LCD-DL40289 · Radiology
HighThe proposed LCD for non-invasive arterial duplex ultrasound of the upper and lower extremities may lead to supports compliance with updated rates for providers in the relevant specialties. This could i
View alertProposed LCD DL40332: Automated Detection and Quantification of Brain MRIs — NGS
Policy LCD-DL40332 · Radiology
HighThe proposed LCD for automated detection and quantification of brain MRIs could streamline the billing process for radiologists and improve reimbursement rates for these services. By standardizing eva
View alert